Natco’s generic for PAH gets USFDA nod, marketing partner Lupin to launch product
Image for representation. Natco Pharma has received U.S. Food and Drug Administration final approval for Bosentan tablets for oral suspension, 32mg, its generic version of Actelion Pharmaceuticals US Inc.’s pulmonary arterial hypertension drug Tracleer. The Hyderabad-based generic drugmaker said it believes it has the sole first-to-file status for the product and consequently eligible for a…
Read More “Natco’s generic for PAH gets USFDA nod, marketing partner Lupin to launch product” »